Literature DB >> 24792662

NMDA receptor hypofunction and the thalamus in schizophrenia.

Zoran Vukadinovic1.   

Abstract

The thalamus can be subdivided into two kinds of nuclei, the higher order (HO) and the first order (FO) relays, which are distinguished based on the origin of their main or driver inputs. The driver inputs to the HO nuclei arrive from the cortex, and the messages they deliver are then relayed to other cortical areas. As the origin of these inputs is the cortical layer V, whose axons branch and innervate lower motor centers in the CNS, the messages are copies of motor instructions issued to those lower motor centers. These copies are thus an integral part of perceptual processes. In schizophrenia, the HO nuclei are shrunken suggesting that a reduced ability to integrate copies of ongoing motor commands in perceptual processes may be one part of the underlying pathophysiology. The driver inputs in the thalamus utilize ionotropic glutamate receptors such as the NMDAR. NMDAR antagonists may exert their pro-psychotic effects by impairing the function of the HO nuclei. Here, we argue that such agents (or the proposed NMDAR hypofunction in schizophrenia) weaken the driver inputs in the HO nuclei, thereby producing a cortico-thalamo-cortical disconnection and impairing sensorimotor integration.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Higher order thalamic nuclei; NMDAR; Psychosis; Sensorimotor gating

Mesh:

Substances:

Year:  2014        PMID: 24792662     DOI: 10.1016/j.physbeh.2014.04.038

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  10 in total

1.  Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysis.

Authors:  Taro Kishi; Yuki Matsuda; Nakao Iwata
Journal:  Psychopharmacology (Berl)       Date:  2017-05-15       Impact factor: 4.530

Review 2.  Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.

Authors:  Xiangyou Hu; Qingyuan Fan; Hailong Hou; Riqiang Yan
Journal:  J Neurochem       Date:  2015-11-13       Impact factor: 5.372

Review 3.  Thalamic Reticular Dysfunction as a Circuit Endophenotype in Neurodevelopmental Disorders.

Authors:  Alexandra Krol; Ralf D Wimmer; Michael M Halassa; Guoping Feng
Journal:  Neuron       Date:  2018-04-18       Impact factor: 17.173

Review 4.  Neurology issues in schizophrenia.

Authors:  Katharina Hüfner; Beatrice Frajo-Apor; Alex Hofer
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

5.  Fast sleep spindle reduction in schizophrenia and healthy first-degree relatives: association with impaired cognitive function and potential intermediate phenotype.

Authors:  Claudia Schilling; Manuel Schlipf; Simone Spietzack; Franziska Rausch; Sarah Eisenacher; Susanne Englisch; Iris Reinhard; Leila Haller; Oliver Grimm; Michael Deuschle; Heike Tost; Mathias Zink; Andreas Meyer-Lindenberg; Michael Schredl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-26       Impact factor: 5.270

6.  Ketamine influences the locus coeruleus norepinephrine network, with a dependency on norepinephrine transporter genotype - a placebo controlled fMRI study.

Authors:  Thomas Liebe; Meng Li; Lejla Colic; Matthias H J Munk; Catherine M Sweeney-Reed; Marie Woelfer; Moritz A Kretzschmar; Johann Steiner; Felicia von Düring; Gusalija Behnisch; Björn H Schott; Martin Walter
Journal:  Neuroimage Clin       Date:  2018-09-04       Impact factor: 4.881

7.  Cre-Activation in ErbB4-Positive Neurons of Floxed Grin1/NMDA Receptor Mice Is Not Associated With Major Behavioral Impairment.

Authors:  Anne S Mallien; Natascha Pfeiffer; Miriam A Vogt; Sabine Chourbaji; Rolf Sprengel; Peter Gass; Dragos Inta
Journal:  Front Psychiatry       Date:  2021-11-25       Impact factor: 4.157

8.  Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia.

Authors:  Samantha V Abram; Brian J Roach; Susanna L Fryer; Vince D Calhoun; Adrian Preda; Theo G M van Erp; Juan R Bustillo; Kelvin O Lim; Rachel L Loewy; Barbara K Stuart; John H Krystal; Judith M Ford; Daniel H Mathalon
Journal:  Mol Psychiatry       Date:  2022-04-14       Impact factor: 13.437

9.  Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia.

Authors:  Kazu Nakazawa; Vivek Jeevakumar; Kazuhito Nakao
Journal:  NPJ Schizophr       Date:  2017-02-03

Review 10.  Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?

Authors:  Alexei M Bygrave; Kasyoka Kilonzo; Dimitri M Kullmann; David M Bannerman; Dennis Kätzel
Journal:  Front Psychiatry       Date:  2019-11-21       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.